Plans initiated to build new CLIA-certified laboratory for early detection of treatable genetic disorders in newborns Expanding in-house clinical testing and research capabilities SEATTLE, March 7, 2024 /PRNewswire/ — Key Proteo, a pioneering proteomics diagnostics company specializing…